-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA).
-
Desloratadine (Clarinex), a major metabolite of loratadine (Claritin), is the newest medication indicated for the treatment of allergic rhinitis. It is often a misconception that new drugs are more beneficial than their predecessors.
-
Another drug besides vaccinia immune globulin (VIG) that may be used to treat certain serious smallpox vaccine reactions is the antiviral drug cidofovir (Vistide).
-
The tracing in the Figure was obtained from a 59-year-old woman with a long history of smoking. She presented with acute dyspnea and atypical chest pain. Because of moderate respiratory difficulty, this was the best quality tracing obtainable. In full acknowledgment of its suboptimal technical quality, how would you interpret this ECG? What findings may be of potential concern?
-
The FDA has approved Atomoxetine (previously named tomoxetine), the first nonstimulant/noncontrolled drug to be approved for the treatment of attention-deficit/hyperactivity disorder (ADHD).
-
The excess risk of Achilles tendon disorders attributable to fluoroquinolone use was estimated to be 3.2 cases per 1000 patient-years, with most of that increase accounted for by patients 60 years of age and older who concomitantly receive corticosteroids.
-
C-reactive protein levels are stronger predictors of first cardiovascular events than low-density lipoprotein cholesterol levels.
-
After years of legal wrangling, the FDA has approved loratadine (Claritin, Schering-Plough) as an over-the-counter (OTC) product for the treatment of seasonal rhinitis.
-
-
Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal Failure; Nut and Peanut Butter Consumption and Risk of Type 2 Diabetes in Women; Optimal Diets for Prevention of CHD